MAFLD: a milestone in the history of fatty liver disease

Our growing understanding of the natural history and pathogenesis of MAFLD and the predominant role of metabolic dysfunction in this disease have evoked efforts to redefine fatty liver disease.
PUBLISHED IN: Hepatobiliary Surg Nutr 2021

Commentary

Our growing understanding of the natural history and pathogenesis of MAFLD and the predominant role of metabolic dysfunction in this disease have evoked efforts to redefine fatty liver disease.

As pointed out by J. Alharthi and M. Eslam (Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Australia), this redefinition process for improving our ability to deliver optimal multidisciplinary care will lead to improved outcomes for these patients and a decreased burden on healthcare systems.

Share the article
Dr. D. Beard

Dr. D. Beard

Articles: 189

Leave a Reply

Your email address will not be published.

SUBSCRIBE & FOLLOW US

SUBSCRIBE TO OUR MONTHLY NEWSLETTER TO GET THE LATEST UPDATES